Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
0.2%
1w
5.0%
1m
1.7%
3m
11.5%
6m
3.0%
1y
32.0%
all
10.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,254 0.2%
1,017
1,400
Company Overview
Sales
1,055 Cr
Growth: 4.0%
Profit after Tax
261 Cr
Growth: -16.5%
Mid Cap
13,121 Cr
P/E: 50.6x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 1,055
Growth 4.0%
EBITDA 34.8%
P/S 12.4x
Dividend 0.6%
P/E 50.6x
Book Value ₹ 193
PEG Ratio 12.7x
ROE 13.4%
P/B 6.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (24 Indices) view more
Followers (1)
varsha96